RAMM Pharma Corp. announced the appointment of José Roldan as interim-Chief Financial Officer of the Company, effective immediately. Mr. Roldan succeeds Mr. Guillermo Delmonte, who is currently on medical leave.
Mr. Roldan is a Public Accountant specializing in audits of financial and commercial institutions. He has extensive experience in the cannabis space coupled with knowledge of central bank regulations and International Financial Reporting Standards. Prior to joining RAMM, Mr. Roldan worked as a senior auditor with KPMG Uruguay for six years.
For more information:
RAMM Pharma 
www.rammpharma.com
Announcements
Job Offers
Top 5 -yesterday
- "Portuguese medical cannabis is already a major market for us"
- Cannabis brands and celebrities: "limited impact so far"
- US (CA): Officials take step toward interstate cannabis commerce
- US (MT): Heavy metal testing, too much THC, and the fight over Montana’s budding cannabis industry
- “With outdoor cultivation from seed we can see variation with each cultivar and select the most robust phenotypes for our microclimate"
Top 5 -last week
- Comparing indoor and outdoor grown cannabis: effects on cannabinoid and terpene profiles
- Curaleaf closes operations in California, Colorado, and Oregon
- “There is a lack of standardization, compliance and education in American cannabis facilities”
- Canopy Growth to auction assets from 4 locations
- Bringing international best practices to New Zealand cannabis
Top 5 -last month
- “Cannabis propagators should consider retipping to expand their liner production”
- Comparing indoor and outdoor grown cannabis: effects on cannabinoid and terpene profiles
- Curaleaf closes operations in California, Colorado, and Oregon
- Capacity reached in 3 days: “There is an insane demand for risk-free cannabis clones”
- “There is a lack of standardization, compliance and education in American cannabis facilities”
RAMM Pharma Corp. appoints new Interim-Chief Financial Officer
Publication date:
Receive the daily newsletter in your email for free | Click here
Other news in this sector:
- 2023-01-30 AU: "Legalizing cannabis could generate tens of billions in revenue"
- 2023-01-26 Autumn Shelton elected to the California Cannabis Industry Association Board of Directors
- 2023-01-26 NL: Bedrocan founder quits, leaves company in hands of his son
- 2023-01-20 Schwazze announces Forrest Hoffmaster as CFO
- 2023-01-19 US (OR): Chalice Brands appoints new members to board of directors
- 2023-01-18 MariMed strengthens sales, marketing, and R&D teams with senior executive hires
- 2023-01-17 Eric Mathur joins ONIT Sciences as Chief Science Officer
- 2023-01-16 CAN (ON): Bassam Alghanim joins The Green Organic Dutchman board of directors
- 2023-01-16 US operator Schwazze announce executive leadership additions
- 2023-01-13 Montel Williams joins Cannformatics' Advisory Board
- 2023-01-12 JT Archer appointed as COO at urban-gro
- 2023-01-11 Jushi Holdings announces leadership appointments and management changes
- 2023-01-10 Cann Group appoints Peter Koetsier as new CEO
- 2022-12-22 Pending an independent investigation, Akanda's CEO on paid leave of absence
- 2022-12-22 Maryland Medical Cannabis Commission's Chair steps down
- 2022-12-21 Delta 9 announces changes to board of directors
- 2022-12-20 Curaleaf adds two new members to the board of directors
- 2022-12-20 Management change at Audacious
- 2022-12-19 InMed announces appointment of Interim Chief Financial Officer and Change of Auditor
- 2022-12-19 MariMed appoints Jon Levine as Interim Chief Executive Officer
